Stay updated on Daratumumab Combo in MRD+ Myeloma Clinical Trial
Sign up to get notified when there's something new on the Daratumumab Combo in MRD+ Myeloma Clinical Trial page.

Latest updates to the Daratumumab Combo in MRD+ Myeloma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page header now shows a site revision update to v3.3.2, replacing the previous v3.3.1. This change does not affect study content or how the page is used.SummaryDifference0.0%

- Check22 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and updated the page revision to v3.3.1, while the older PubMed-related text and the v3.2.0 revision identifier were removed.SummaryDifference0.2%

- Check29 days agoChange DetectedAdded related topic tags for Multiple Myeloma and MedlinePlus Genetics, with updates dated 2025-11-13 and 2025-11-06. Removed a government funding status notice (last updated 2025-10-17 and 2025-10-09).SummaryDifference0.4%

- Check37 days agoChange DetectedRemoved mentions of 'Multiple Myeloma' and related topics (MedlinePlus Genetics) from the page. This reduces disease context and related resource links on the study page.SummaryDifference0.1%

- Check44 days agoChange DetectedNo additions or deletions were detected; the study details page appears unchanged between the old and new screenshots.SummaryDifference0.3%

- Check72 days agoChange DetectedIntroducing a government-funded operation notice and hospital status link, along with updating the version from v3.1.0 to v3.2.0. If there are no other functional changes, this marks an operational status update and version increment.SummaryDifference2%

Stay in the know with updates to Daratumumab Combo in MRD+ Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo in MRD+ Myeloma Clinical Trial page.